XML 23 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Jun. 30, 2014
CURRENT ASSETS:    
Cash and cash equivalents $ 5,662 $ 4,493
Short-term bank deposits 14,494 19,451
Restricted cash and restricted short-term deposits 5,083 4,914
Marketable securities 25,898 29,961
Account receivable from OCS 451 2,263
Other current assets 704 905
Total current assets 52,292 61,987
LONG-TERM ASSETS:    
Long-term deposits and restricted deposits 289 304
Severance pay fund 706 901
Property and equipment, net 10,541 10,823
Other long term assets 2 8
Total long-term assets 11,538 12,036
Total assets 63,830 74,023
CURRENT LIABILITIES    
Trade payables 2,421 3,465
Accrued expenses 1,003 915
Deferred revenues 379 379
Advance payment from United Therapeutics 218 247
Other accounts payable 1,964 2,391
Total current liabilities 5,985 7,397
LONG-TERM LIABILITIES    
Deferred revenues 2,752 2,847
Accrued severance pay 832 1,068
Other long-term liabilities 566 588
Total long-term liabilities 4,150 4,503
STOCKHOLDERS' EQUITY    
Share capital: Common stock $0.00001 par value: Authorized: 200,000,000 shares issued and outstanding: 69,585,642 shares as of September 30, 2014, 68,601,452 shares as of June 30, 2014      
Additional paid-in capital 174,169 172,998
Accumulated deficit (119,745) (113,834)
Other comprehensive income (loss) (729) 2,959
Total stockholders' equity 53,695 62,123
Total liabilities and stockholders' equity $ 63,830 $ 74,023